Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

A 'first-of-a-kind' daily pill for endometriosis has been approved by NHS England. But how effective is it, how does it work ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

Current GnRH agonists can be given as injections or with an implant (which is injected under the skin) and lasts for 4 – 12 weeks. There is also a quicker onset in symptoms management without ...

Some children receiving gonadotropin-releasing hormone (GnRH) agonists ... treatment will typically go away a few weeks after their injection. Talk with your child’s doctor if you have questions ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...